Products and Research
Develop innovative drugs to safeguard human health
RD Center
With the mission of "Develop innovative drugs to safeguard human health", YZYBIO has established a visionary and seasoned R&D team and an integrated research and development platform, continuing to develop innovative technologies and product pipelines to develop BsAb-based therapies treatments for cancer or cancer-associated complications, cancer and age-related ophthalmologic diseases. The Company has established a pipeline of multiple drug candidates,of which four candidates (including M701, Y332, Y400 and Y225) are at the clinical development stage and two candidates (Y232 and Y180) are at the preclinical research stage.
Phone：
027-82668988
E-Mail：info@yzybio.com
Address：Biolake, C2-1, No. 666 High-tech Avenue, Wuhan, Hubei, China
Share
